Sofie Wilgenhof
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
- Oncology 28
- Cancer Immunotherapy and Biomarkers 23
- Cutaneous Melanoma Detection and Management 4
- Immunology 16
- Immunotherapy and Immune Responses 16
- Co-authors
- Bart Neyns (32 shared papers)Jurgen Corthals (15 shared papers)John B.A.G. Haanen (26 shared papers)Kris Thielemans (15 shared papers)Maartje W. Rohaan (8 shared papers)Carlo Heirman (14 shared papers)Aude Bonehill (13 shared papers)An M. T. Van Nuffel (12 shared papers)
- Journals
- Annals of Oncology (15 papers)Melanoma Research (6 papers)Cancer Immunology Immunotherapy (4 papers)European Journal of Cancer (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)
- Partner nations
- NetherlandsBelgiumItaly
In The Last Decade
Sofie Wilgenhof
83 papers receiving 4.4k citations
Sofie Wilgenhof's Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 1.7k
- Immunology 815
- Cancer Research 239
- Pulmonary and Respiratory Medicine 229
- Molecular Biology 387
Countries citing papers authored by Sofie Wilgenhof
This map shows the geographic impact of Sofie Wilgenhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Wilgenhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Wilgenhof more than expected).
Fields of papers citing papers by Sofie Wilgenhof
This network shows the impact of papers produced by Sofie Wilgenhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Wilgenhof. The network helps show where Sofie Wilgenhof may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofie Wilgenhof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial Hit paper breakdown → | 2019 | 759 |
| 2 | Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma Hit paper breakdown → | 2022 | 399 |
| 3 | Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma Hit paper breakdown → | 2024 | 320 |
| 4 | 2018 | 319 | |
| 5 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors Hit paper breakdown → | 2021 | 299 |
| 6 | 2016 | 267 | |
| 7 | 2013 | 184 | |
| 8 | 2011 | 156 | |
| 9 | 2011 | 131 | |
| 10 | 2020 | 131 | |
| 11 | 2016 | 125 | |
| 12 | 2012 | 110 | |
| 13 | 2012 | 87 | |
| 14 | 2014 | 82 | |
| 15 | Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor. | 2012 | 81 |
| 16 | 2013 | 75 | |
| 17 | 2013 | 71 | |
| 18 | 2014 | 68 | |
| 19 | 2011 | 60 | |
| 20 | 2012 | 46 |
About Sofie Wilgenhof
Sofie Wilgenhof is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and General Health Professions, having authored 84 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), Immunotherapy and Immune Responses (16 papers), Melanoma and MAPK Pathways (12 papers), Renal cell carcinoma treatment (5 papers), Cutaneous Melanoma Detection and Management (4 papers), Mobile Health and mHealth Applications (2 papers), Nonmelanoma Skin Cancer Studies (2 papers) and Chemotherapy-related skin toxicity (1 paper). The work is most often cited by research in Oncology (1.7k citations), Immunology (815 citations), Cancer Research (239 citations), Pulmonary and Respiratory Medicine (229 citations) and Molecular Biology (387 citations). Sofie Wilgenhof has collaborated with scholars based in Netherlands, Belgium and Italy. Frequent co-authors include Bart Neyns, Jurgen Corthals, John B.A.G. Haanen, Kris Thielemans, Maartje W. Rohaan, Carlo Heirman, Aude Bonehill, An M. T. Van Nuffel, Daphné Benteyn and Nicolas van Baren. Their work appears in journals such as Annals of Oncology, Melanoma Research, Cancer Immunology Immunotherapy, European Journal of Cancer and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.